Bank of Montreal’s Checkpoint Therapeutics CKPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-139
Closed -$4K 3885
2021
Q1
$4K Sell
139
-686
-83% -$23K ﹤0.01% 4709
2020
Q4
$22K Buy
825
+616
+295% +$15.6K ﹤0.01% 4372
2020
Q3
$6K Sell
209
-122
-37% -$2.93K ﹤0.01% 4331
2020
Q2
$6K Buy
+331
New +$6.03K ﹤0.01% 4367
2020
Q1
Sell
-321
Closed -$6K 4181
2019
Q4
$6K Sell
321
-24
-7% -$402 ﹤0.01% 4657
2019
Q3
$8K Sell
345
-137
-28% -$3.76K ﹤0.01% 4477
2019
Q2
$15K Buy
+482
New +$18.9K ﹤0.01% 4329

Other funds holding CKPT

Bank of Montreal's CKPT Position: Q2 2021 in Review

Bank of Montreal sold out of Checkpoint Therapeutics (CKPT) in Q2 2021, closing a stake of 139 shares — an estimated $4K sold.

Bank of Montreal first reported a position in CKPT in Q2 2019 and held it in 7 quarters. The position peaked at $22K in Q4 2020. 69 funds tracked by Wall St. Rank hold CKPT as of Q2 2021.

  • Bank of Montreal reported no remaining Checkpoint Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 139 Checkpoint Therapeutics shares in Q2 2021, an estimated $4K.
  • Bank of Montreal first reported a position in Checkpoint Therapeutics in Q2 2019 and held it in 7 quarters.
  • Bank of Montreal's Checkpoint Therapeutics position peaked at $22K in Q4 2020.
  • 69 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.